Adaptive protein evolution may be facilitated by neutral amino acid mutations that confer no benefit when they first arise but which potentiate subsequent function-altering mutations via direct or indirect structural mechanisms. Theoretical and empirical results indicate that such compensatory interactions (intramolecular epistasis) can exert a strong influence on trajectories of protein evolution. For this reason, assessing the form and prevalence of intramolecular epistasis and characterizing biophysical mechanisms of compensatory interaction are important research goals at the nexus of structural biology and molecular evolution. Here I review recent insights derived from protein-engineering studies, and I describe an approach for identifying and characterizing mechanisms of epistasis that integrates experimental data on structure-function relationships with analyses of comparative sequence data.
Introduction
A number of important questions about mechanisms of protein evolution concern the context-dependence of mutational effects ('epistasis'). Do amino acid mutations produce the same functional effect regardless of sequence context (i.e. regardless of the amino acid states of other sites in the same protein), or do their effects depend on the sequence context in which they occur? Epistatic interactions between mutant sites in the same protein can help explain why evolution follows some pathways rather than others [1-5,6 ,7 ,8 ] . If the sign of a mutation's fitness effect is conditional on genetic background ('sign epistasis'), then pairs of mutations that are individually neutral or beneficial may be deleterious in combination. In such cases, some fraction of all possible mutational pathways connecting ancestral and descendant genotypes will be selectively inaccessible because they include incompatible mutational combinations as intermediate steps [9] [10] [11] [12] [13] [14] [15] 16 ,17,18 ]. Conversely, pairs of mutations that are individually deleterious may be neutral or beneficial in combination, thereby opening up new pathways through sequence space that previously would have been off limits.
Intramolecular epistasis has important implications for biochemical adaptation and the evolution of novel protein functions. The evolution of an advantageous change in protein function may be facilitated by neutral mutations that confer no benefit when they first arise but which lay the groundwork for subsequent function-altering mutations. For example, an amino acid mutation at site X may produce a subtle change in protein conformation or stability that -by itself -is functionally inconsequential, but the altered structural context may change the functional effect of subsequent mutations at other sites in the same protein [4,5,7 ,15,19-22] . The mutation at site X is neutral when it first arises, but by facilitating the fixation of a beneficial, function-altering mutation at site Y, it then becomes deleterious to revert site X to its ancestral state. Likewise, the mutation at site Y is beneficial on a background in which the mutation at site X has already occurred, but otherwise it would be neutral or deleterious. In principle, the compensatory change at site X could precede the functionaltering change at site Y (in which case it is called a 'permissive' substitution), or it could occur afterwards, in which case there would be a transient reduction in fitness. In principle, the two mutations could also be fixed simultaneously if they co-occurred on the same sequence haplotype [23, 24] . Evidence for epistatic fitness effects prompts us to view the longstanding 'selectionist/neutralist' debate through a new prism since a given mutation may be neutral, beneficial, or deleterious depending on the genetic background in which it occurs.
Compensatory substitutions are central to questions about the role of historical contingency in shaping pathways and outcomes of protein evolution. If the fitness effects of amino acid mutations are conditional on genetic background, then mutations can have different effects depending on the sequential order in which they occur [2] . Consequently, the accumulated history of substitutions in the past will influence the set of allowable mutations in the future, and evolutionary outcomes will be historically contingent on ancestral starting points [7 ,8 ,12,14,25-27] .
The role of intramolecular epistasis in protein evolution
Insights from protein-engineering experiments occur on the divergent genetic background of a different species. Likewise, within a single line of descent, substitutions may have different phenotypic effects depending on the sequential order in which they occur. Site-directed mutagenesis experiments that swap residues between orthologs of contemporary species [28, 32, 33] or between ancestral and descendant sequences [9,17,18 ,34-37] have revealed pervasive epistasis for functional properties or fitness proxies. These experimental findings are generally consistent with results of theoretical and computational analyses [38-41,42 ,43,44,45 ,46] and in silico simulations [47, 48 ] . By contrast, other experimental studies that focused on mutational perturbations of structural stability have suggested a less important role for epistasis during longterm protein evolution [49] [50] [51] .
Genetic compensation of pathogenic mutations
Additional insights into the prevalence of epistasis and the nature of genetic compensation are provided by cases where a pathogenic amino acid mutation in a human protein appears as the wildtype residue at the same site in the orthologous protein of one or more nonhuman species [52] (Figure 2 ). In such cases, the pathogenic variant is invariably present at low frequency in the human gene pool, but the same amino acid is fixed (present at a frequency of 1.0) in the nonhuman species. In order for the disease-associated residue (DAR) to become fixed in the nonhuman species, its deleterious effects must have been compensated by one or more substitutions at other sites in the same protein or in an interacting protein. This permits an indirect inference of sign epistasis for fitness: the DAR produces a deleterious effect in the human protein, but is neutral in the nonhuman ortholog due to genetic compensation [52] [53] [54] [55] [56] [57] [58] 59 ].
The pathogenicity of amino acid mutations often stems from their negative effects on protein structural stability [60] , and evidence suggests that the destabilizing effects of such DARs are sometimes partly or wholly compensated by substitutions at structurally proximal residue positions [52,55,56,58,59 ,61,62] . For example, Xu and Zhang [58] demonstrated that uncompensated DARs in human proteins are associated with lower average structural stabilities than the corresponding wildtype DARs in cases where the latter are accompanied by one or more lineage-specific substitutions at residue positions within a 4 Å radius of the DAR. This finding suggests that one or more of the observed substitutions in the nonhuman background compensate for the destabilizing effect of the DAR.
In cases where compensatory substitutions have not been identified, there are other possible explanations for the existence of wild-type DARs that do not invoke sign epistasis for fitness [54] . For example, the observation that a DAR is wildtype in a given species does not rule out the possibility that it has a mildly deleterious effect, as such mutations can fix due to drift, especially in small or bottlenecked populations [63] . This is unlikely to be a general explanation, however, especially in cases where the wildtype DAR is shared by multiple species within the same clade. A number of wildtype DARs have been documented in laboratory mice (Mus domesticus) [53] , but the majority of these are shared by multiple species of Mus that diverged over one million years ago, so they clearly do not represent deleterious variants that were fixed as a result of founder effects during the history of mouse breeding and domestication [54] .
Rather than using the identification of wildtype DARs to indirectly infer sign epistasis for fitness, a similar approach can be used to infer sign epistasis for biochemical phenotypes without making assumptions about fitness effects. This is possible in cases where we have detailed information about structure-function relationships. For example, in the case of human hemoglobin (Hb), crystallographic and NMR studies of mutant Hbs have provided exquisitely detailed insights into the structural mechanisms responsible for observed functional effects of specific amino acid replacements. In cases where a particular mutation in human Hb is known to alter a particular functional property, it is often possible to Indirect evidence for genetic compensation is provided by cases where a pathogenic amino acid mutation in a human protein appears as the wildtype residue at the same site in the orthologous protein of one or more nonhuman species. The pathogenic hemoglobin (Hb) mutant, Hb Mequon (b41Phe!Tyr), provides an illustrative example. Although the Hb Mequon mutation is associated with severe hemolytic anemia in humans, the disease-associated b41Tyr is wildtype in Mus and Rattus. In order for the Tyr variant to become fixed in the common ancestor of these rodent taxa, the deleterious effects that are manifest in human Hb must have been compensated by one or more rodent-specific substitutions at other sites in the same protein.
identify Hbs from nonhuman species in which the same amino acid is wildtype and yet the property of interest is not altered in the same way. In such cases the connection between genotype and biochemical phenotype can be experimentally tested. By contrast, associations with disease states do not generally permit direct insights into the mapping functions that relate genotype to phenotype or phenotype to fitness.
Molecular basis of the Bohr effect: a case study of genetic compensation
The Hbs of jawed vertebrates are heterotetramers, composed of paired ab dimers (a 2 b 2 ) that undergo a symmetrical rotation during oxygenation-linked transitions in quaternary structure [64] . This allosteric transition is mediated by a conformational equilibrium between the low-affinity, deoxygenated 'T state' and the high-affinity, oxygenated 'R state'. Hb-O 2 affinity is reduced at low pH because protons preferentially bind and stabilize deoxyHb, thereby shifting the allosteric equilibrium in favor of the low-affinity T conformation [65] . Because Hb-O 2 affinity decreases with reductions in pH over the physiological range (6.6-7.6), the metabolic acidosis of capillary blood induces Hb to release O 2 to the tissues that need it most. This pH-sensitivity of Hb-O 2 affinity is known as the Bohr effect.
At physiological pH and temperature, the Bohr effect of human Hb is mainly attributable to the oxygenationlinked deprotonation of surface histidines because their imidazole side chains typically have acid dissociation constants, pK a 's, in the physiological pH range [66] . The C-terminal histidine of the b-chain, b146His, makes an outsized contribution, accounting for 60% of the Bohr effect in the presence of 0.1 M chloride [67] . In deoxy (T state) Hb, the positive charge on the imidazole sidechain of b146His is stabilized by formation of a salt bridge with the carbonyl group of b94Asp in the same b-chain subunit (Figure 3 ). This ionization of the b146His side chain substantially raises its pK a in the deoxy T state. Consequently, mutational replacements of either b146His or b94Asp result in a severely diminished Bohr effect because the b94Asp-b146His saltbridge in the T state is replaced by an unionizable hydrogen bond; thus, no protons are released in the allosteric T!R transition in quaternary structure. Surprisingly, substitutions at these highly conserved residue positions have been identified in the Hbs of several 
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The structural basis for the Bohr effect in tetrameric (a 2 b 2 ) human Hb. (a, b) The C-terminal His of each b-chain subunit (b146His) participates in two electrostatic interactions in the deoxy (T) state. The positively charged imidazole side chain of b146His forms an intrasubunit salt bridge with b94Asp (which increases its pK a ) and its negatively charged carboxyl group forms an intradimer salt bridge with a40Lys. (c) When Hb is oxygenated, the allosteric transition in quaternary structure shifts the triad of residues apart from one another, outside the range of electrostatic interaction. The consequent rupturing of the b146His-b94Asp salt bridge results in the deprotonation of the His side chain (two protons are released per tetramer), which makes a major contribution to the Bohr effect.
vertebrate species that do not have reduced Bohr effects [68] [69] [70] . For example, human Hb mutants such as Hb Bologna-St. Orsola (b146His!Tyr) and Hb Kodaira (b146His!Gln) exhibit increased O 2 -affinities (due to destabilization of the T-state) and severe reductions in the Bohr effect [71, 72] . Remarkably, the same amino acid states are observed as wildtype in the adult Hbs of the dwarf caiman (Paleosuchus palpebrosus) (b146Tyr) and the golden-mantled ground squirrel (Callospermophilus lateralis) (b146Gln), and yet the Hbs of both species exhibit Bohr effects that are undiminished relative to normal human Hb [68, 69] (Figure 4 ). In the case of both caiman and ground-squirrel Hb, the loss of a single key residue with a major effect on pH-sensitivity, b146His, appears to be compensated by the lineage-specific gain of multiple solvent-exposed, titratable histidines with individually minor effects [68, 69] .
In the case of b94Asp, human Hb mutants such as Hb Barcelona (b94Asp!His) and Hb Bunbury (b94Asp!Asn) also exhibit marked increases in O 2 -affinity and concomitant reductions in the Bohr effect due to the disruption of the b94Asp-b146His intrachain salt bridge. In two different species of high-altitude Andean waterfowl (crested duck In the Hbs of amniote vertebrates, comparative sequence analysis and experimental data on structure-function relationships reveal intramolecular epistasis for the Bohr effect. In the b-chain subunit of vertebrate Hb, the highly conserved b146His generally accounts for a major fraction of the Bohr effect [66, 67, 71, 72] . This is well-documented by experimental studies of naturally occurring human Hb mutants which demonstrate that mutational replacements of b146His (H) with Asp (D), Tyr (Y), Arg (R), Leu (L), Pro (P), or Gln (Q) invariably result in a severely diminished Bohr effect. Surprisingly, however, two of these amino acid states, Q (Hb Kodaira) and Y (Hb Bologna-St. Orsola), occur as wildtype in the Hbs of two nonhuman vertebrates, golden-mantled ground squirrel (Callospermophilus lateralis) and dwarf caiman (Paleosuchus palpebrosus), respectively, and yet the Hbs of both species exhibit Bohr effects that are undiminished relative to normal human Hb [68, 69] . In both species, the aggregate effect of other lineage-specific substitutions (e.g. gains of solvent-exposed histidines at other sites in the a-chains and/or b-chains of the Hb tetramer) may have rendered b146His redundant with respect to oxygenation-linked proton binding, so it could therefore be replaced without unduly compromising the Bohr effect.
to wildtype Hbs with the ancestral b94Asp [70] . A consideration of the crystal structure of avian Hb provides a clear explanation for this result [67] , as the b94Asp-b146His salt bridge is not formed in the deoxy T conformation, so the amino acid state of b94 does not affect the pK a of b146His. This may also explain why the b146His!Tyr substitution in dwarf caiman Hb is not associated with a diminished Bohr effect relative to the Hbs of other crocodilians, and demonstrates how 'major effect' Bohr groups in human Hb may have minor or nonexistent effects in the Hbs of other species. These examples also illustrate how subtle changes in the threedimensional orientation of highly conserved amino acids (caused by substitutions at other sites) can alter the functional effects of substitutions at those conserved sites [73] .
Conclusions and future directions
Efforts to elucidate mechanisms of epistasis represent a nexus between the fields of structural biology and molecular evolution [1, 5, 74 ]. An especially important question is whether permissive/compensatory mutational effects are typically localized and specific, or whether they typically involve generalized effects on global properties such as structural stability. If function-altering mutations can only be compensated by mutations with localized and specific effects (e.g. via direct steric or electrostatic sidechain interactions between structurally proximal residues), then accessible mutational pathways to novel functions may be fortuitously contingent on the acquisition of exceedingly rare mutations [7 ,25] . By contrast, there is a much larger mutational target size for perturbations of overall structural stability, so destabilizing, function-altering mutations may be effectively compensated by stabilizing mutations at many possible residue positions in the same protein, and the compensatory effect would not require direct site-site interaction. If deleterious pleiotropic effects of adaptive, function-altering mutations can be effectively compensated by such global suppressor mutations, then the optimizing power of selection should be considerably less constrained and evolutionary outcomes will be less strongly contingent on ancestral starting points.
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Kaltenbach M, Jackson CJ, Campbell EC, Hollfelder F, Tokuriki N: Reverse evolution leads to genotypic incompatibility despite functional and active site convergence. eLife 2015, 4:e06492. The authors conducted a directed evolution experiment which revealed that a PTE enzyme that had evolved a novel function (arylesterase activity) could be reverted to its ancestral function (phosphotriesterase activity). Interestingly, however, the ancestral catalytic activity was restored via the fixation of new mutations, not by reverting mutations that had fixed during evolution of the derived arylesterase activity. This finding demonstrates how the ancestral state of a given site can become incompatible with derived states at other sites in the same protein, thereby inhibiting mutational reversions. 
